These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8768925)
21. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency]. Dimković N Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study. Albertazzi A; Di Liberato L; Daniele F; Battistel V; Colombi L Int J Artif Organs; 1998 Jan; 21(1):12-8. PubMed ID: 9554820 [TBL] [Abstract][Full Text] [Related]
23. [The efficacy and safety of continuous erythropoietin receptor activator in dialytic patients with chronic renal anemia: an open, randomized, controlled, multi-center trial]. Chen N; Qian JQ; Mei CL; Zhang AH; Xing CY; Wang L; Liu WH; Wang M; Chen JH; Liu BC; Hou FF; Chen XM; Zuo L; Shi W; Yu LB; Zhang Y Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):502-7. PubMed ID: 22943819 [TBL] [Abstract][Full Text] [Related]
24. Low 1,25-dihydroxyvitamin D level is associated with erythropoietin deficiency and endogenous erythropoietin resistance in patients with chronic kidney disease. Kim IY; Kim JH; Kim MJ; Lee DW; Hwang CG; Han M; Rhee H; Song SH; Seong EY; Lee SB Int Urol Nephrol; 2018 Dec; 50(12):2255-2260. PubMed ID: 30136086 [TBL] [Abstract][Full Text] [Related]
25. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180 [TBL] [Abstract][Full Text] [Related]
27. The therapeutic role of recombinant erythropoietin in anemic patients with intact endogenous production of erythropoietin. Erslev AJ Semin Oncol; 1992 Jun; 19(3 Suppl 8):14-8. PubMed ID: 1615334 [TBL] [Abstract][Full Text] [Related]
28. [Study of recombinant human erythropoietin treatment on the anemia of predialysis patients]. Furukawa A; Numata A; Imagawa A; Kaifu Y; Sumikura T; Miyake H; Obayashi S; Nakazora H; Hirohata M; Miki S Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):693-700. PubMed ID: 1479709 [TBL] [Abstract][Full Text] [Related]
29. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy. Ludwig H; Sundal E; Pecherstorfer M; Leitgeb C; Bauernhofer T; Beinhauer A; Samonigg H; Kappeler AW; Fritz E Cancer; 1995 Dec; 76(11):2319-29. PubMed ID: 8635038 [TBL] [Abstract][Full Text] [Related]
30. Erythropoietin for the treatment of anemia associated with hematological malignancy. Littlewood TJ Hematol Oncol; 2001 Mar; 19(1):19-30. PubMed ID: 11276043 [TBL] [Abstract][Full Text] [Related]
31. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. Moreno F; Aracil FJ; Pérez R; Valderrábano F Am J Kidney Dis; 1996 Apr; 27(4):548-56. PubMed ID: 8678066 [TBL] [Abstract][Full Text] [Related]
32. Is recombinant human erythropoietin (rh-epo) more than just a treatment of anemia in cancer and chemotherapy? Taylor SK Med Hypotheses; 2003 Jan; 60(1):89-93. PubMed ID: 12450771 [TBL] [Abstract][Full Text] [Related]
34. Erythropoietin metabolism and pharmacokinetics in experimental nephrosis. Zhou XJ; Vaziri ND Am J Physiol; 1992 Nov; 263(5 Pt 2):F812-5. PubMed ID: 1443172 [TBL] [Abstract][Full Text] [Related]
35. Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation. Locatelli F; Pedrazzoli P; Barosi G; Zecca M; Porta F; Liberato L; Gambarana D; Nespoli L; Cazzola M Br J Haematol; 1992 Apr; 80(4):545-9. PubMed ID: 1581240 [TBL] [Abstract][Full Text] [Related]
36. Iron metabolism under rEPO therapy in patients on maintenance hemodialysis. Bergmann M; Grützmacher P; Heuser J; Kaltwasser JP Int J Artif Organs; 1990 Feb; 13(2):109-12. PubMed ID: 2347653 [TBL] [Abstract][Full Text] [Related]
37. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy. Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972 [TBL] [Abstract][Full Text] [Related]
38. Serum erythropoietin levels in patients with severe anemia secondary to inflammatory bowel disease and the use of recombinant human erythropoietin in patients with anemia refractory to treatment. Demirtürk L; Hülagü S; Yaylaci M; Altin M; Ozel M Dis Colon Rectum; 1995 Aug; 38(8):896-7. PubMed ID: 7634987 [No Abstract] [Full Text] [Related]